TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
LTRN

Lantern Pharma Inc

Healthcare · Biotechnology

1.60$ -9.4% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement LTRN
Line item 2018 2019 2020 2021 2022 2023 2024 2025
+108.2% +2,775.5% +58.8% +13.0% +9.0% -90.9%
-164.0%
+66.6% +135.3% +237.5% +113,536.7% -99.9% +35.6% -28.6%
+27.8% +148.5% +37.0% +116,010.0% -99.9% +1.8% +6.1%
+40.6% +143.3% +113.1% +114,522.9% -99.9% +25.5% -19.1%
-7.8%
-100.2%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?